<DOC>
	<DOCNO>NCT03058627</DOCNO>
	<brief_summary>The aim study evaluate effect routine FFR-guided complete revascularization PCI compare conservative management patient concomitant coronary artery disease undergo TAVI .</brief_summary>
	<brief_title>Revascularization Patients Undergoing Transcatheter Aortic Valve Implantation</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Severe aortic valve stenosis* select TAVI multidisciplinary Heart Team 3 . Concomitant CAD ( least one stenosis FFR &lt; 0.80 diameter stenosis &gt; 90 % ) And one following : 1 . Symptomatic ( dyspnea correspond New York Heart Association ( NYHA ) class II high , angina pectoris , cardiac syncope ) 2 . Asymptomatic decline leave ventricular ejection fraction ( LVEF ) , new onset atrial fibrillation , LV septal hypertrophy 1 . Life expectancy &lt; 1 year due severe noncardiac disease 2 . Severe renal failure estimate glomerular filtration rate &lt; 20 ml/min 3 . No PCIeligible coronary artery stenosis , rotablation allow 4 . Admitted new acute coronary syndrome ( STelevation myocardial infarction ( STEMI ) nonSTEMI ) within 14 day 5 . Significant stenosis leave main stenosis , leave main equivalent ( proximal leave anterior descend artery ( LAD ) + proximal leave circumflex artery ( LCx ) ) proximal LAD + proximal right coronary artery ( RCA ) 6 . Only stenoses thrombolysis myocardial infarction grad &lt; 3 7 . Potential pregnancy 8 . Known allergy towards P2Y12 receptor antagonist , heparin contrast medium 9 . More one chronic total occlusion ( CTO )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>